Technology | Mammography | March 15, 2019

Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System

New features will be on display at the National Consortium of Breast Centers conference and the Society of Breast Imaging Symposium

Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System

March 15, 2019 — Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory requirements for three new image processing and software advancements for its digital mammography system, Aspire Cristalle. Specifically, S-View, Iterative Super-resolution Reconstruction (ISR) and Tomosynthesis Spot — innovative tools designed to meet the dual challenge of higher image quality and lower dose — are now commercially available in the United States.

The Aspire Cristalle system with these latest features will be showcased at Fujifilm's booth at both the National Consortium of Breast Centers (NCoBC) conference, March 15-20 in Las Vegas, and the Society of Breast Imaging (SBI) Symposium, April 4-7 in Hollywood, Fla.

The following three new features were designed for the Aspire Cristalle with digital breast tomosynthesis (DBT):

  • S-View: Enabling radiologists to view a synthesized 2-D image reconstructed from DBT, an S-View image can be used together with tomosynthesis slice image for both screening and diagnosis. The tool provides a high level of detail but low noise within the synthetic image, delivering images that are similar in appearance to 2-D. By using S-View images instead of dedicated 2-D, it is possible to reduce dose as much as about 50 percent for examinations (when only tomosynthesis exposure is performed instead of both 2-D and tomosynthesis exposures).
  • Iterative Super-resolution Reconstruction (ISR): A new reconstruction process derived from auto-recognition technologies, ISR aims to improve both image detail and noise characteristics compared to filtered backprojection techniques. An improvement on conventional iterative reconstruction techniques, ISR reconstructs images at a finer resolution than the readout data, leading to enhanced detail and reduced noise without compromising the speed of image acquisition.
  • Tomosynthesis Spot: Developed for an advanced view for tomosynthesis images, the technique focuses compression for a precise visualization of a specific area of concern.

The Aspire Cristalle digital mammography system offers the DBT option and dose-saving Hexagonal Close Pattern (HCP) image capture technology for 20 percent improvement in dose efficiency (compared to square pixel arrays). It offers a full-field digital mammography image pixel size of 50µm and features innovations to optimize contrast, enable low dose and decrease acquisition time, all while providing noticeable improvement to patient comfort with Fujifilm's patented Comfort Paddle.

For more information: www.fujimed.com

Related Content

myExam Companion user interface on both systems helps technologists of every experience level achieve consistently high image quality
News | Digital Radiography (DR) | January 25, 2021
January 25, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density

Getty Images

Feature | Women's Health | January 20, 2021 | By Fazila Seker, Ph.D.
Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recen
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant the

A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant therapy shows new mass (arrow) in upper outer left breast that was assessed as BI-RADS 4. Pathologic examination from MRI-guided core biopsy of new suspicious mass revealed benign usual ductal hyperplasia. No atypia or malignancy was identified. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | MRI Breast | January 15, 2021
January 15, 2021 — According to ARRS' ...